NASDAQ:BABY - Natus Medical Stock Price, News & Analysis

$31.92
+5.17 (+19.33 %)
(As of 08/2/2019)
Today's Range
$0.61
Now: $31.92
$0.61
50-Day Range
$25.36
MA: $28.03
$32.15
52-Week Range
$23.53
Now: $31.92
$37.90
Volume289,334 shs
Average Volume165,325 shs
Market Capitalization$1.09 billion
P/E Ratio22.48
Dividend YieldN/A
Beta0.57
Natus Medical Incorporated provides neurology, newborn care, and hearing and balance assessment healthcare products and services worldwide. It offers products and services used for the screening, diagnosis, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction and neurosurgical treatments, epilepsy, sleep disorders, neuromuscular diseases, and balance and mobility disorders. Read More…

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:BABY
CUSIP63905010
Phone925-223-6700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$530.89 million
Cash Flow$3.3994 per share
Book Value$11.80 per share

Profitability

Net Income$-22,930,000.00

Miscellaneous

Employees1,729
Market Cap$1.09 billion
Next Earnings Date10/23/2019 (Estimated)
OptionableOptionable

Receive BABY News and Ratings via Email

Sign-up to receive the latest news and ratings for BABY and its competitors with MarketBeat's FREE daily newsletter.


Natus Medical (NASDAQ:BABY) Frequently Asked Questions

What is Natus Medical's stock symbol?

Natus Medical trades on the NASDAQ under the ticker symbol "BABY."

How will Natus Medical's stock buyback program work?

Natus Medical announced that its Board of Directors has authorized a stock buyback plan on Thursday, February 22nd 2018, which permits the company to repurchase $30,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to reacquire shares of its stock through open market purchases. Stock repurchase plans are usually an indication that the company's leadership believes its stock is undervalued.

How were Natus Medical's earnings last quarter?

Natus Medical Inc (NASDAQ:BABY) released its earnings results on Thursday, July, 25th. The medical equipment provider reported $0.34 EPS for the quarter, topping analysts' consensus estimates of $0.30 by $0.04. The medical equipment provider had revenue of $125.50 million for the quarter, compared to analyst estimates of $122.85 million. Natus Medical had a positive return on equity of 10.79% and a negative net margin of 7.38%. Natus Medical's revenue for the quarter was down 4.0% compared to the same quarter last year. During the same period in the previous year, the business posted $0.35 EPS. View Natus Medical's Earnings History.

When is Natus Medical's next earnings date?

Natus Medical is scheduled to release their next quarterly earnings announcement on Wednesday, October 23rd 2019. View Earnings Estimates for Natus Medical.

What guidance has Natus Medical issued on next quarter's earnings?

Natus Medical updated its FY19 earnings guidance on Thursday, July, 25th. The company provided earnings per share (EPS) guidance of $1.19-1.32 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.27. The company issued revenue guidance of $492-500 million, compared to the consensus revenue estimate of $495.95 million.

What price target have analysts set for BABY?

2 analysts have issued 12-month price targets for Natus Medical's shares. Their predictions range from $36.00 to $36.00. On average, they expect Natus Medical's stock price to reach $36.00 in the next twelve months. This suggests a possible upside of 12.8% from the stock's current price. View Analyst Price Targets for Natus Medical.

What is the consensus analysts' recommendation for Natus Medical?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Natus Medical in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Natus Medical.

Has Natus Medical been receiving favorable news coverage?

Press coverage about BABY stock has trended negative this week, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Natus Medical earned a media sentiment score of -2.3 on InfoTrie's scale. They also assigned news articles about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for Natus Medical.

Who are some of Natus Medical's key competitors?

What other stocks do shareholders of Natus Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Natus Medical investors own include Starbucks (SBUX), Gilead Sciences (GILD), Walt Disney (DIS), Intel (INTC), Activision Blizzard (ATVI), Celgene (CELG), Alphabet (GOOG), NVIDIA (NVDA), Skyworks Solutions (SWKS) and Tesla (TSLA).

Who are Natus Medical's key executives?

Natus Medical's management team includes the folowing people:
  • Mr. Jonathan A. Kennedy CPA, Pres, CEO & Director (Age 48)
  • Mr. Benjamin Drew Davies, Exec. VP & CFO (Age 53)
  • Mr. Austin F. Noll III, Exec. VP & Chief Commercial Officer (Age 52)
  • Mr. Seán Langan, VP Global Operations
  • Mr. Ivan Pandiyan, VP of Global R&D

Who are Natus Medical's major shareholders?

Natus Medical's stock is owned by many different of retail and institutional investors. Top institutional investors include BlackRock Inc. (15.07%), Janus Henderson Group PLC (9.57%), Janus Henderson Group PLC (9.57%), Vanguard Group Inc. (8.21%), Silvercrest Asset Management Group LLC (4.74%) and Cramer Rosenthal Mcglynn LLC (4.51%). Company insiders that own Natus Medical stock include Austin Francis Noll III, Dong Chune Christopher Chung, James B Hawkins, Jonathan Kennedy, Ken Ludlum, Lisa Wipperman Heine, Robert A Gunst and William M Moore. View Institutional Ownership Trends for Natus Medical.

Which institutional investors are selling Natus Medical stock?

BABY stock was sold by a variety of institutional investors in the last quarter, including Starboard Value LP, Price T Rowe Associates Inc. MD, Confluence Investment Management LLC, Rutabaga Capital Management LLC MA, Invesco Ltd., Alambic Investment Management L.P., Bank of America Corp DE and Impax Asset Management Group plc. Company insiders that have sold Natus Medical company stock in the last year include Austin Francis Noll III, Dong Chune Christopher Chung, Jonathan Kennedy, Ken Ludlum and Robert A Gunst. View Insider Buying and Selling for Natus Medical.

Which institutional investors are buying Natus Medical stock?

BABY stock was acquired by a variety of institutional investors in the last quarter, including Cramer Rosenthal Mcglynn LLC, Nuveen Asset Management LLC, Voce Capital Management LLC, Renaissance Technologies LLC, Morgan Stanley, D. E. Shaw & Co. Inc., Wells Fargo & Company MN and BlackRock Inc.. View Insider Buying and Selling for Natus Medical.

How do I buy shares of Natus Medical?

Shares of BABY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Natus Medical's stock price today?

One share of BABY stock can currently be purchased for approximately $31.92.

How big of a company is Natus Medical?

Natus Medical has a market capitalization of $1.09 billion and generates $530.89 million in revenue each year. The medical equipment provider earns $-22,930,000.00 in net income (profit) each year or $1.42 on an earnings per share basis. Natus Medical employs 1,729 workers across the globe.View Additional Information About Natus Medical.

What is Natus Medical's official website?

The official website for Natus Medical is http://www.natus.com/.

How can I contact Natus Medical?

Natus Medical's mailing address is 6701 KOLL CENTER PARKWAY SUITE 120, PLEASANTON CA, 94566. The medical equipment provider can be reached via phone at 925-223-6700 or via email at [email protected]


MarketBeat Community Rating for Natus Medical (NASDAQ BABY)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  266 (Vote Outperform)
Underperform Votes:  293 (Vote Underperform)
Total Votes:  559
MarketBeat's community ratings are surveys of what our community members think about Natus Medical and other stocks. Vote "Outperform" if you believe BABY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BABY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel